Search Results

Filter
  • 1-10 of  9,312 results for ""Vascular Endothelial Growth Factor Receptor-3""

Your Filters

Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

The pathological roles and potential mechanisms of vascular endothelial growth factor receptor-3 in gastric cancer.

  • Authors : Li XF; Department of Pathology, Weifang People's Hospital, the First Affiliated Hospital of Weifang Medical College, Weifang, Shandong Province, China.; Zhang XJ

Subjects: Stomach Neoplasms*/Stomach Neoplasms*/Stomach Neoplasms*/pathology ; Vascular Endothelial Growth Factor Receptor-3*/Vascular Endothelial Growth Factor Receptor-3*/Vascular Endothelial Growth Factor Receptor-3*/genetics; Animals

  • Source: The Journal of international medical research [J Int Med Res] 2024 Mar; Vol. 52 (3), pp. 3000605241234558.Publisher: Sage Publications Country of Publication: England NLM ID: 0346411 Publication Model: Print Cited Medium: Internet ISSN: 1473-2300

Record details

×
Academic Journal

VEGFR-3 signaling in macrophages: friend or foe in disease?

  • Authors : Kannan S; Department of Medical Physiology, Texas A&M University School of Medicine, Bryan, TX, United States.; Rutkowski JM

Subjects: Vascular Endothelial Growth Factor Receptor-3*/Vascular Endothelial Growth Factor Receptor-3*/Vascular Endothelial Growth Factor Receptor-3*/metabolism ; Lymphangiogenesis*/Lymphangiogenesis*/Lymphangiogenesis*/physiology; Vascular Endothelial Growth Factor A/Vascular Endothelial Growth Factor A/Vascular Endothelial Growth Factor A/metabolism

  • Source: Frontiers in immunology [Front Immunol] 2024 Feb 22; Vol. 15, pp. 1349500. Date of Electronic Publication: 2024 Feb 22 (Print Publication: 2024).Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet

Record details

×
Academic Journal

Lymphangiogenic responses of lymphatic endothelial cells to steady direct-current electric fields.

  • Authors : Guan L; Laboratory of Genetic Disease and Perinatal Medicine, Key Laboratory of Birth Defects and Related Diseases of Women and Children of the Ministry of Education, West China Second University Hospital, Sichuan University, Chengdu, China.; Fan P

Subjects: Vascular Endothelial Growth Factor Receptor-3*/Vascular Endothelial Growth Factor Receptor-3*/Vascular Endothelial Growth Factor Receptor-3*/metabolism ; Vascular Endothelial Growth Factor Receptor-3*/Vascular Endothelial Growth Factor Receptor-3*/Vascular Endothelial Growth Factor Receptor-3*/pharmacology ; Lymphangiogenesis*

  • Source: Cell adhesion & migration [Cell Adh Migr] 2023 Dec; Vol. 17 (1), pp. 1-14. Date of Electronic Publication: 2023 Oct 27.Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101469464 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Vascular endothelial growth factor-C in activating vascular endothelial growth factor receptor-3 and chemokine receptor-4 in melanoma adhesion.

  • Authors : Hlophe YN; Department of Physiology, University of Pretoria, Pretoria, South Africa.; Joubert AM

Subjects: Melanoma*/Melanoma*/Melanoma*/genetics ; Vascular Endothelial Growth Factor C*/Vascular Endothelial Growth Factor C*/Vascular Endothelial Growth Factor C*/metabolism ; Vascular Endothelial Growth Factor Receptor-3*/Vascular Endothelial Growth Factor Receptor-3*/Vascular Endothelial Growth Factor Receptor-3*/metabolism

  • Source: Journal of cellular and molecular medicine [J Cell Mol Med] 2022 Dec; Vol. 26 (23), pp. 5743-5754. Date of Electronic Publication: 2022 Nov 17.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 101083777 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Expression and Function of VEGFRs in Normal Epidermis and Psoriatic Lesional Keratinocytes.

  • Authors : Wang Y; School of Medicine, Yichun University, Yichun, 336000, China. .; Yan Y

Subjects: Vascular Endothelial Growth Factor Receptor-3*/Vascular Endothelial Growth Factor Receptor-3*/Vascular Endothelial Growth Factor Receptor-3*/genetics ; Psoriasis*/Psoriasis*/Psoriasis*/genetics; Humans

  • Source: Cellular and molecular biology (Noisy-le-Grand, France) [Cell Mol Biol (Noisy-le-grand)] 2023 Aug 31; Vol. 69 (8), pp. 50-56. Date of Electronic Publication: 2023 Aug 31.Publisher: C.M.B. Association Country of Publication: France NLM ID: 9216789 Publication Model: Electronic Cited Medium: Internet ISSN: 1165-158X

Record details

×
Academic Journal

VEGFR3 suppression through miR-1236 inhibits proliferation and induces apoptosis in ovarian cancer via ERK1/2 and AKT signaling pathways.

  • Authors : Babaei Z; Department of Clinical Biochemistry, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, Iran.; Panjehpour M

Subjects: MicroRNAs*/MicroRNAs*/MicroRNAs*/metabolism ; Ovarian Neoplasms*/Ovarian Neoplasms*/Ovarian Neoplasms*/genetics ; Vascular Endothelial Growth Factor Receptor-3*/Vascular Endothelial Growth Factor Receptor-3*/Vascular Endothelial Growth Factor Receptor-3*/genetics

  • Source: Journal of cellular biochemistry [J Cell Biochem] 2023 May; Vol. 124 (5), pp. 674-686. Date of Electronic Publication: 2023 Mar 15.Publisher: Wiley-Liss Country of Publication: United States NLM ID: 8205768 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

VEGFR3 is required for button junction formation in lymphatic vessels.

  • Authors : Jannaway M; Department of Molecular Pharmacology and Physiology, Morsani College of Medicine, University of South Florida, Tampa, FL 33612, USA.; Iyer D

Subjects: Endothelial Cells*/Endothelial Cells*/Endothelial Cells*/metabolism ; Lymphatic Vessels*/Lymphatic Vessels*/Lymphatic Vessels*/metabolism ; Vascular Endothelial Growth Factor Receptor-3*/Vascular Endothelial Growth Factor Receptor-3*/Vascular Endothelial Growth Factor Receptor-3*/genetics

  • Source: Cell reports [Cell Rep] 2023 Jul 25; Vol. 42 (7), pp. 112777. Date of Electronic Publication: 2023 Jul 16.Publisher: Cell Press Country of Publication: United States NLM ID: 101573691 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

High VEGFR3 Expression Reduces Doxorubicin Efficacy in Triple-Negative Breast Cancer.

Subjects: Doxorubicin*/Doxorubicin*/Doxorubicin*/pharmacology ; Doxorubicin*/Doxorubicin*/Doxorubicin*/therapeutic use ; Triple Negative Breast Neoplasms*/Triple Negative Breast Neoplasms*/Triple Negative Breast Neoplasms*/drug therapy

  • Source: International journal of molecular sciences [Int J Mol Sci] 2023 Feb 10; Vol. 24 (4). Date of Electronic Publication: 2023 Feb 10.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067

Record details

×
Academic Journal

Formation of the glomerular microvasculature is regulated by VEGFR-3.

  • Authors : Donnan MD; Northwestern University Feinberg School of Medicine, Feinberg Cardiovascular and Renal Research Institute, Chicago, Illinois.; Deb DK

Subjects: Vascular Endothelial Growth Factor Receptor-3*/Vascular Endothelial Growth Factor Receptor-3*/Vascular Endothelial Growth Factor Receptor-3*/genetics ; Vascular Endothelial Growth Factor Receptor-3*/Vascular Endothelial Growth Factor Receptor-3*/Vascular Endothelial Growth Factor Receptor-3*/metabolism ; Kidney Diseases*

  • Source: American journal of physiology. Renal physiology [Am J Physiol Renal Physiol] 2023 Jan 01; Vol. 324 (1), pp. F91-F105. Date of Electronic Publication: 2022 Nov 17.Publisher: American Physiological Society Country of Publication: United States NLM ID: 100901990 Publication Model: Print-Electronic Cited Medium:

Record details

×
  • 1-10 of  9,312 results for ""Vascular Endothelial Growth Factor Receptor-3""